Education and knowledge transfer must be prioritized for industry to see sizable improvement in medical affairs.
Lisa Sigl
Advertisement
Director, Executive Insight, Healthcare Consultants
Articles by Lisa Sigl
How can companies adapt their single evidence package at launch into multiple, tailored versions for HTAs that vary across different countries and regions?
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Pfizer Receives Unsolicited Mini-Tender Offer for 1 Million Shares from Tutanota: Report
2
Why CMS Is Tightening ASP Reporting and What Manufacturers Must Get Right
3
Gilead Sciences Enters $2.1 Billion Definitive Agreement to Acquire Ouro Medicines
4
Quotient Therapeutics Enters Research Collaboration with Merck to Discover Drug Targets in Inflammatory Bowel Disease
5